Regulator

Summary of regulator annotations and link-out to annotation databases

Basic gene annotations are collected from Uniprot and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser is available.

NR3C2 - nuclear receptor subfamily 3 group C member 2

Function

Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels.

Uniprot Browser
Entrez IDEnsEMBL IDPreferred NameUniprot ID
4306 ENSG00000151623 NR3C2 P08235

List of causal flows containing the regulator.

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulonthat contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows with ENSG00000151623 as Regulator

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00080LRP2up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-03845DSPup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-04115JAG2up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-06483LGSNup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-14375ST18down-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-15051PTENup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-18007PRPF40Bup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-24961NLRP1up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-26041PITX2up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-27547CXorf57down-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-29790SLC5A7up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB